867 related articles for article (PubMed ID: 1503399)
1. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.
Stinson SF; Alley MC; Kopp WC; Fiebig HH; Mullendore LA; Pittman AF; Kenney S; Keller J; Boyd MR
Anticancer Res; 1992; 12(4):1035-53. PubMed ID: 1503399
[TBL] [Abstract][Full Text] [Related]
2. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
Banks-Schlegel SP; Gazdar AF; Harris CC
Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.
Wu L; Smythe AM; Stinson SF; Mullendore LA; Monks A; Scudiero DA; Paull KD; Koutsoukos AD; Rubinstein LV; Boyd MR
Cancer Res; 1992 Jun; 52(11):3029-34. PubMed ID: 1350507
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
Rosen ST; Mulshine JL; Cuttitta F; Fedorko J; Carney DN; Gazdar AF; Minna JD
Cancer Res; 1984 May; 44(5):2052-61. PubMed ID: 6713399
[TBL] [Abstract][Full Text] [Related]
5. Protodioscin (NSC-698 796): its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel.
Hu K; Yao X
Planta Med; 2002 Apr; 68(4):297-301. PubMed ID: 11988850
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
Putz E; Witter K; Offner S; Stosiek P; Zippelius A; Johnson J; Zahn R; Riethmüller G; Pantel K
Cancer Res; 1999 Jan; 59(1):241-8. PubMed ID: 9892213
[TBL] [Abstract][Full Text] [Related]
7. Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation.
Bergh J; Nilsson K; Dahl D; Andersson L; Virtanen I; Lehto VP
Lab Invest; 1984 Sep; 51(3):307-16. PubMed ID: 6206304
[TBL] [Abstract][Full Text] [Related]
8. Peripheral airway cell differentiation in human lung cancer cell lines.
Gazdar AF; Linnoila RI; Kurita Y; Oie HK; Mulshine JL; Clark JC; Whitsett JA
Cancer Res; 1990 Sep; 50(17):5481-7. PubMed ID: 2386953
[TBL] [Abstract][Full Text] [Related]
9. The cytotoxicity of methyl protoneodioscin (NSC-698791) against human cancer cell lines in vitro.
Hu K; Yao XS
Anticancer Res; 2002; 22(2A):1001-5. PubMed ID: 12014616
[TBL] [Abstract][Full Text] [Related]
10. Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines.
Levitt ML; Gazdar AF; Oie HK; Schuller H; Thacher SM
Cancer Res; 1990 Jan; 50(1):120-8. PubMed ID: 1967140
[TBL] [Abstract][Full Text] [Related]
11. Expression of neuroendocrine and epithelial markers in an adherent subline derived from a classic small cell lung cancer cell line.
Walker C; Wright-Perkins S
Oncol Res; 1992; 4(10):419-29. PubMed ID: 1337994
[TBL] [Abstract][Full Text] [Related]
12. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
14. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
15. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.
Takahashi T; Ueda R; Song X; Nishida K; Shinzato M; Namikawa R; Ariyoshi Y; Ota K; Kato K; Nagatsu T
Cancer Res; 1986 Sep; 46(9):4770-5. PubMed ID: 3015397
[TBL] [Abstract][Full Text] [Related]
16. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis.
van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ
Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278
[TBL] [Abstract][Full Text] [Related]
17. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
19. The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
Hu K; Yao X
Phytother Res; 2003 Jun; 17(6):620-6. PubMed ID: 12820229
[TBL] [Abstract][Full Text] [Related]
20. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.
Alvarez M; Paull K; Monks A; Hose C; Lee JS; Weinstein J; Grever M; Bates S; Fojo T
J Clin Invest; 1995 May; 95(5):2205-14. PubMed ID: 7738186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
